Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by JeremyBauherkon Dec 10, 2018 2:42pm
147 Views
Post# 29093070

What benefit is there for a R/S to shareholders?

What benefit is there for a R/S to shareholders?Had mgmt at HUGE chosen in August to undertake a 1 for 20 R/S (from 10 cents to $2) before the great 900%+ spike from 10 cents to 94 cents, would the pps have gone on to rocket that 900% from $2 to $18? I doubt it. Mgmt at ISOL also suggested that their R/S would only be feasible if it came with institutional backing. Institutions were nowhere to be seen. Sure, ISOL's outstanding share count was reduced by 10 after the R/S from 30 cents to $3, but what good did that do in preventing the persistent debacles all the way to $1.03 last week? Did ISOL not fare much better on oversold conditions combined with hype between 7 cents and 2.14? And after collapsing from that 2.14 high all the way to 30 cents, would ISOL shareholders not have much preferred to trust hype to carry it beyond $1 once more? What most penny stock investors initially like about a penny stock company is its penny stock price. When penny stock companies facilitate the illusion that they are suddenly large caps after a R/S, investors are brought to realize that the original penny stock premise has gone out the window. What comes about is what is most expected, that is, a lack of trust for post R/S prices, a downturn in investor interest, a non-existent institutional presence and repeated pps debacles. A penny stock R/S, a benefit to shareholders? I'll believe it when I see it. Until that time, I feel much safer buying HUGE, even ISOL, after each debacle to new lows for a 10, 20, 30%+ rebound that is most often sure to come about.
Bullboard Posts